发明名称 |
THE DIAGNOSIS, PREVENTION, AND/OR TREATMENT OF ATHEROSCLEROSIS AND UNDERLYING AND/OR RELATED DISEASES |
摘要 |
Complement is recognized as an important, humoral defense system involved in the innate (nonspecific) recognition and elimination of microbial invaders, other foreign particles or molecules, and antigen-antibody complexes form th e body. The present invention makes use of the surprising notion that the handling of lipids by the body, rather than its antimicrobial activity, is t he primary and most ancient function of the complement system. Consequently, atherosclerosis as observed in disorders associated with disturbed lipid metabolism (familial combined hyperlipemia [FCHL], postprandial hyperlipidemia, hypertriglyceridemia with low levels of HDL cholesterol, and insulin resistance associated with type-II diabetes and obesity), must be ascribed to either genetic or acquired defects in ancient (activatory and/or regulatory) complement components. Based on this new insight, novel preventi ve measures and treatment modalities of disturbed lipid metabolism are introduc ed. |
申请公布号 |
CA2421994(A1) |
申请公布日期 |
2002.03.21 |
申请号 |
CA20012421994 |
申请日期 |
2001.09.12 |
申请人 |
UNIVERSITAIR MEDISCH CENTRUM UTRECHT;UNIVERSITEIT UTRECHT |
发明人 |
CASTRO CABEZAS, MANUEL;VAN DIJK, HANS |
分类号 |
A23L33/00;A61K31/454;A61K38/00;A61K38/17;A61K38/39;A61K38/46;A61K38/48;A61K39/39;A61K39/395;A61K45/00;A61K47/44;A61K48/00;A61P3/00;A61P3/06;A61P7/00;A61P9/10;A61P29/00;A61P31/00;A61P35/00;A61P37/00;A61P37/02;A61P37/06;A61P43/00;C12Q1/02;G01N33/564;G01N33/68;G01N33/92 |
主分类号 |
A23L33/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|